During this meeting, the advisory committee will: Review available safety and efficacy data for BPC-157, including preclinical studies and any available clinical evidence Consider public comments submitted by patients, practitioners, and industry stakeholders Evaluate the clinical need for compounded BPC-157 and the patient populations that would benefit Assess the compounding quality considerations specific to peptide formulations Issue a recommendation to the FDA on whether BPC-157 should be included on the 503A compounding list Possible outcomes include: Positive recommendation: PCAC advises the FDA to add BPC-157 to the 503A list, clearing the way for legal compounding nationwide
[12] According to a patent, "Short duration safety studies with dihexa have uncovered no apparent toxicity
Common side effects include nausea, constipation, and diarrhoea, typically most pronounced during dose escalation periods
Vehicle-treated mice received 10% DMSO, 40% PEG300, 5% Tween-80 and 45% saline
Prepare Your Medication To make sure the medication is at the correct temperature, allow the vial to reach room temperature after removing it from the refrigerator
Beginner Tip: Start with push-ups against a wall, then progress to incline push-ups on a sturdy surface (like a table or stairs), then knee push-ups on the floor
